To assess the oncogenic potential of PRPS isoforms, we initially compared the mRNA levels of PRPS1 and PRPS2 in 47 cases of lung adenocarcinoma specimens with paired adjacent normal tissues (Supplementary Tables 1, 2). This evidence concerns the gene MSMB and lung adenocarcinoma.